Language Select
Logotipo de Varian

Press Releases

Octubre 20, 2018
To expand the encouraging preclinical and translational research already conducted by Varian (NYSE: VAR) and two of its clinical partners, Maryland Proton Treatment Center and Cincinnati... Read more
Octubre 20, 2018
Varian (NYSE: VAR) today announced its new single-room proton therapy system, ProBeam® 360°. With a 30 percent smaller footprint than the previous system, ProBeam 360° offers uncompromised... Read more
Octubre 12, 2018
Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported... Read more
Octubre 04, 2018
Varian (NYSE: VAR) today announced it has signed an educational partnership with one of India's leading hospital groups to provide greater access to training in advanced radiotherapy and... Read more
Octubre 03, 2018
Varian (NYSE: VAR), today announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (VOS) to a new role as president of Proton Solutions, the division formerly... Read more
Octubre 01, 2018
Varian (NYSE: VAR) today announced a 75-year-old male with throat cancer was the first patient in India to be treated on the Halcyon™ system at Sterling Cancer Hospital in Gujarat. Halcyon... Read more
Septiembre 20, 2018
The phrase "You have cancer" understandably strikes fear into the hearts of millions of patients diagnosed with the disease every year around the world. But what if we lived in a world without the... Read more
Septiembre 12, 2018
Varian (NYSE: VAR) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt University School of... Read more
Septiembre 07, 2018
Varian (NYSE: VAR) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya. This comprehensive partnership agreement includes the supply of... Read more
Septiembre 04, 2018
Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on the campus of the Delray... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com